SCHEMBL22563041

SCHEMBL22563041

N#Cc1ccc(Nc2ccccc2C(F)(F)F)cc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 2/20 0.56
SLC22A12 Q96S37 6/20 0.46
AR P10275 4/20 0.44
MAPT P10636 2/20 0.43
TEAD1 P28347 1/20 0.43
TEAD4 Q15561 1/20 0.43
TEAD2 Q15562 1/20 0.43
MAPK1 P28482 1/20 0.43
CACNA1B Q00975 1/20 0.43
APBA1 Q02410 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PGR P06401 2/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
MAPK14 Q16539 1/20 0.41
ACP1 P24666 1/20 0.40
TRPV4 Q9HBA0 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22551191 0.83 TAS2R14 (0.46) TAS2R14MAPTPGRABCG2MAPK14
SCHEMBL6834456 0.79 TAS2R14 (0.43) TAS2R14SLC22A12MAPTMAPK1CACNA1B
SCHEMBL673038 0.79 AR (0.49) TAS2R14ARPGRMAPK14
SCHEMBL16481443 0.77 SLC22A12 (0.55) TAS2R14SLC22A12MAPTTEAD1TEAD4
SCHEMBL16481048 0.77 SLC22A12 (0.57) TAS2R14SLC22A12ARMAPTTEAD1
SCHEMBL16481026 0.77 ACP1 (0.61) TAS2R14SLC22A12MAPTTEAD1TEAD4
SCHEMBL1921413 0.76 ALDH1A1 (0.57) TAS2R14MAPTTEAD1TEAD4TEAD2
SCHEMBL184908 0.74 ALDH1A1 (0.42) TAS2R14SLC22A12MAPTMAPK14ACP1
SCHEMBL1935112 0.73 AURKA (0.47) TAS2R14MAPTTEAD1TEAD4TEAD2
SCHEMBL16481153 0.73 ACP1 (0.54) TAS2R14MAPTNPSR1MAPK14ACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2022-02-10 US disclosed
WO-2020212530-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2020-10-22 WO disclosed
EP-3725777-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech S.r.l. (IT) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS PDXK, MAP4K2, PLK2 TAS2R14 4048/4885SLC22A12 4330/4885AR 3678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.